Silence Therapeutics (SLNCF) Current Assets (2019 - 2025)
Historic Current Assets for Silence Therapeutics (SLNCF) over the last 7 years, with Q3 2025 value amounting to $133.6 million.
- Silence Therapeutics' Current Assets fell 3470.39% to $133.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.6 million, marking a year-over-year decrease of 3470.39%. This contributed to the annual value of $187.4 million for FY2024, which is 8164.24% up from last year.
- According to the latest figures from Q3 2025, Silence Therapeutics' Current Assets is $133.6 million, which was down 3470.39% from $148.6 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Current Assets registered a high of $230.5 million during Q1 2024, and its lowest value of -$13.3 million during Q3 2021.
- Its 5-year average for Current Assets is $132.6 million, with a median of $122.0 million in 2021.
- In the last 5 years, Silence Therapeutics' Current Assets soared by 110761.81% in 2022 and then tumbled by 3470.39% in 2025.
- Over the past 5 years, Silence Therapeutics' Current Assets (Quarter) stood at $116.4 million in 2021, then dropped by 2.55% to $113.4 million in 2022, then fell by 11.33% to $100.6 million in 2023, then surged by 86.32% to $187.4 million in 2024, then dropped by 28.68% to $133.6 million in 2025.
- Its last three reported values are $133.6 million in Q3 2025, $148.6 million for Q2 2025, and $169.8 million during Q1 2025.